The ability to tolerate aggression is partly genetic, UCLA life scientists report in the first study to demonstrate a genetic component to a social network trait in a non-human population.
"The ability to tolerate aggression is passed on across generations; there is genetic variation in the ability to tolerate aggression," said the study co-author Daniel T. Blumstein, professor and chair of ecology and evolutionary biology at UCLA.
HACKENSACK, N.J. (December 7, 2010 at 7:30am) — The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings presented at the annual meeting of the American Society of Hematology (ASH) taking place December 4-7, 2010 in Orlando, Florida. The ASH meeting is the world's leading scientific gathering of hematologists and hematology researchers.
Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options. The findings are published in the January 1 issue of The Journal of Infectious Diseases. (Please see below for links to these articles online.)
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
"Although newborn screening undoubtedly saves lives, some families are thrown on a journey of great uncertainty," said UCLA sociology professor Stefan Timmermans, the study's lead author. "Rather than providing clear-cut diagnoses, screening of an entire population has created ambiguity about whether infants truly have a disease — and even what the disease is."
WASHINGTON, DC, December 6, 2010 — Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
The London School of Hygiene & Tropical Medicine (LSHTM) has contributed to a study showing that a low dose of aspirin reduces the occurrence of several common cancers. The study is published in today's Lancet.
The work was started and carried out by Professor Peter Rothwell in Oxford, and is based on an overview of several randomised trials of aspirin. These have been primarily concerned with reducing heart attacks, but have also gathered information on deaths from cancer.
Pregnant mums who regularly use mobile phones may be more likely to have kids with behavioural problems, particularly if those children start using mobile phones early themselves, suggests research published online in the Journal of Epidemiology and Community Health.
The researchers base their findings on more than 28,000 seven year olds and their mothers who were part of the Danish National Birth Cohort (DNBC) study.
This study enrolled nearly 100,000 pregnant women between 1996 and 2002, with the intention of tracking their kids' long term health.
When people with irritable bowel syndrome (IBS) were asked to relate their mood to a color, those choosing a positive color were nine times more likely to respond to hypnotherapy than those who chose a negative color or no color at all. Researchers writing in the open access journal BMC Complementary and Alternative Medicine suggest that these findings could be used to predict responders to treatment.
Hanging out with healthy friends could be the best way to keep fit. A study of 3610 Australian women, published in BioMed Central's open access International Journal of Behavioral Nutrition and Physical Activity found that physical activity and healthy eating behavior were both strongly affected by social norms.
CHAPEL HILL, N.C. – A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.
"This study may be the best result ever for patients whose diabetes is inadequately controlled on a combination of pills and insulin," said John Buse, MD, PhD, lead author of the study and chief of the Division of Endocrinology and Metabolism in the University of North Carolina at Chapel Hill School of Medicine.
ORLANDO ––– In research to be presented at the American Society of Hematology (ASH) annual meeting, investigators at Dana-Farber Cancer Institute in Boston offer a new explanation of why chronic lymphocytic leukemia (CLL) tends to recur in the lymph nodes and bone marrow after being cleared from the bloodstream by chemotherapy. Their findings will be reported during in an oral session on Monday, Dec. 6, at 4:45 p.m. in room 315 of the Orange County Convention Center.
ST. PAUL, Minn. – Women with transient restless legs syndrome (RLS) during pregnancy appear to be at a higher risk of developing a chronic form of RLS later in life or have the same symptoms during future pregnancies, according to new research published in the December 7, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. RLS is a sleep-related motor disorder that causes an unpleasant feeling in the legs. The condition generally worsens during rest at night and improves with movement. Symptoms tend to progress with age.
DALLAS, Dec. 6, 2010 — High blood pressure may help to explain why deaths from heart disease and stroke vary according to geography, race and sex, researchers reported in Hypertension: Journal of the American Heart Association.
Only about one-fourth of children participating in organized sports—such as baseball, softball or soccer—receive the government-recommended amount of physical activity during team practices, according to a report posted online today that will appear in the April 2011 print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
WHAT: The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.